Clinical Trials Logo

Hematocrit Change clinical trials

View clinical trials related to Hematocrit Change.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06284850 Recruiting - Clinical trials for Cardiovascular Prevention

Empagliflozin and Red Blood Cell 2,3-biphosphoglycerate Levels

Start date: November 30, 2023
Phase:
Study type: Observational

The aim of this study is to investigate the hypothesis that treatment with empagliflozin may have an impact on red blood cell 2,3-biphosphoglycerate levels affecting tissue oxygen supply and thus mediating part of the cardio- and reno- protective effect of SGLT-2 inhibitors.